Subscribe to receive this FREE daily commentary directly in your email
December 8, 2019
Stocks: NFLX, TSLA, GILD, ILMN, REGN, SWKS
Macro: SPY
MICHAEL KRAMER AND THE CLIENTS OF MOTT CAPITAL OWN NFLX, TSLA, SWKS
Reading The Market Premium Content:
- The Week Ahead For 12.9.19 – Energy Stocks On Watch
- A Year-End Rally May Only Be Starting
- Stock Market Nearing Big Break Out
- Morning Commentary- 12.6.19 – Jobs Suggest Economy Reaccerlating
S&P 500 (SPY)
Stocks will try to pick up where they left off on Monday, following the strong jobs report. This week will feature CPI, PPI, the Fed, and the ECB. With that, the S&P 500 will try to advance to 3,200 its next level of significant resistance based on a projection of the current patterns. 
Netflix (NFLX)
Netflix is set up to rise into the final few weeks of the year after it emerged from a falling wedge pattern late last week. I first noted this technical setup in a mid-day commentary – Waiting On Jobs Data.
Again the pattern suggests the stock rises to around $320.
Tesla (TSLA)
It is a little bit early, but we should see some “leaked” emails about how production and deliveries are going for the fourth quarter. Meanwhile, there is still a gap that needs to be filled up at $360. That is likely where the stock is heading over the final few weeks.
Gilead (GILD)
Gilead has been testing resistance around the $67.50 level. A rise above that price gets the stock moving to $72. The RSI is trending higher, and it suggests the stock moves higher.
Regeneron (REGN)
Regeneron is another biotech stock that appears to be heading higher towards resistance at $392.
Illumina (ILMN)
Illumina may also be heading higher, with that huge gap to fill up to resistance at $360.
Skyworks (SWKS)
Skyworks is breaking out rising above resistance at $100, and that could push shares higher towards $111.
Have a good week!
-Mike
Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future results.
Subscribe to receive this FREE daily commentary directly in your email
This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment.
Cycles Warn of End of Year Pain Trade - Advanced Topics
Mott Capital's Market Chronicles 4 hours ago